Towards better management of disinhibition in frontotemporal dementia
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023
Research, science & health
New drug candidate slows the progression of adrenoleukodystrophy
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023
Research, science & health
NADYA PYATIGORSKAYA: The hopes of imaging and neuromodulation in rare diseases
Le Dr Nadya Pyatigorskaya est neuroradiologue à l’Hôpital Pitié-Salpêtrière AP-HP et chercheuse dans l’équipe MOV’IT à l’Institut du Cerveau. Elle revient sur son parcours et ses travaux à l’Institut du Cerveau
12.19.2022
Portraits
The C-BRAINS international PhD program is launching its call
The C-BRAINS international PhD program is launching its call for applications for 13 doctoral contracts, including 5 provided by the Paris Brain Institute.
12.16.2022
Teaching & training
Cognitive fatigue: new insight on biological mechanisms
A study by the Brain Institute (ICM/Inserm/CNRS/Sorbonne University/AP-HP) establishes for the first time the link between the onset of cognitive fatigue and the accumulation of a neurotransmitter called glutamate in a particular region of the brain...
12.11.2022
Research, science & health
Molecular characterization of primary lymphomas of the central nervous system towards a better prediction of evolution and personalized treatments
Researchers and clinicians from the research team co-directed by Prof. Marc SANSON and Emmanuelle HUILLARD at the Paris Brain Institute have just identified four molecular profiles of primary central nervous system lymphoma (PCNSL) that could predict...
12.07.2022
Research, science & health
Paris Brain Institute at the society for Neuroscience International Meeting in San Diego
Each year, more than 1,000 scientists from around the world gather at the Society For Neuroscience (SFN) conference to learn about new advances in the field and share their works. In 2022, this congress will be held from November 12 to 16 in San...
11.10.2022
Events
A new anti-inflammatory mechanism identified
The team " Plasticity and regeneration of myelin" co-directed by Brahim NAIT-OUMESMAR, Inserm Research Director at the Paris Brain Institute - in collaboration with Angela Giangrande's team (IGBMC, Illkirch) has just demonstrated that the Gcm2 gene...
10.25.2022
Research, science & health
How to discern impulsivity from alteration of anticipation?
In everyday life, we all need to anticipate our actions. On the road, for example, we need to start or cross when the light turns green. While the light is red, our brain prepares to act as quickly as possible as soon as the color changes because we...
10.13.2022
Research, science & health
Paris Brain Institute becomes associated member of EBRAINS AISBL
Paris Brain Institute is pleased to announce its membership to EBRAINS AISBL, a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research.
10.13.2022
Research applications
In the brains of procrastinators
A research team from Inserm, CNRS, Sorbonne University and AP-HP at the Paris Brain Institute in Paris just deciphered how our brain behaves when we procrastinate. The study, conducted in humans, combines functional imaging and behavioral testing. It...
10.12.2022
Research, science & health
Transcranial Magnetic Stimulation, what happens in the brain?
Transcranial Magnetic Stimulation (TMS) is a non-invasive stimulation procedure that uses transient electromagnetic fields to act in a focused manner on a particular brain region. It can be used as a therapy for depression, Parkinson's disease or...
10.06.2022
Research, science & health